YU92103A - Granulirani preparati gaboksadola - Google Patents

Granulirani preparati gaboksadola

Info

Publication number
YU92103A
YU92103A YU92103A YUP92103A YU92103A YU 92103 A YU92103 A YU 92103A YU 92103 A YU92103 A YU 92103A YU P92103 A YUP92103 A YU P92103A YU 92103 A YU92103 A YU 92103A
Authority
YU
Yugoslavia
Prior art keywords
gaboxadol
granular preparations
preparation
granular
dosage forms
Prior art date
Application number
YU92103A
Other languages
English (en)
Inventor
Michiel Onne Elema
Lene Andresen
Per Holm
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of YU92103A publication Critical patent/YU92103A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Sadašnji pronalazak se odnosi na granulirani proizvod koji sadrži gaboksadol kao kiselu adicionu so, postupak granulacije topljenjem za njegovo pripremanje, i na čvrste farmaceutski jedinične oblike doze pripremljene iz navedenog granuliranog preparata gaboksadola.[The present invention relates to a granulated product containing gaboxadol as an acid addition salt, a melt granulation process for the preparation thereof and to solid pharmaceutical unit dosage forms prepared from said granular preparation of gaboxadol.
YU92103A 2001-05-21 2002-05-17 Granulirani preparati gaboksadola YU92103A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100817 2001-05-21

Publications (1)

Publication Number Publication Date
YU92103A true YU92103A (sh) 2006-05-25

Family

ID=8160520

Family Applications (1)

Application Number Title Priority Date Filing Date
YU92103A YU92103A (sh) 2001-05-21 2002-05-17 Granulirani preparati gaboksadola

Country Status (26)

Country Link
US (1) US20040157876A1 (sh)
EP (1) EP1389091A1 (sh)
JP (1) JP2004530695A (sh)
KR (1) KR20030097890A (sh)
CN (1) CN1511026A (sh)
AR (1) AR033896A1 (sh)
AU (1) AU2002338855B2 (sh)
BG (1) BG108441A (sh)
BR (1) BR0209834A (sh)
CA (1) CA2447603A1 (sh)
CZ (1) CZ20033269A3 (sh)
EA (2) EA200700703A1 (sh)
HR (1) HRP20030950A2 (sh)
HU (1) HUP0400051A2 (sh)
IL (1) IL158733A0 (sh)
IS (1) IS7020A (sh)
ME (1) MEP6308A (sh)
MX (1) MXPA03010596A (sh)
NO (1) NO20035146D0 (sh)
NZ (1) NZ547636A (sh)
PL (1) PL366541A1 (sh)
SK (1) SK15542003A3 (sh)
UA (1) UA80092C2 (sh)
WO (1) WO2002094225A1 (sh)
YU (1) YU92103A (sh)
ZA (1) ZA200308594B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2385749A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
PL1641456T3 (pl) 2003-06-25 2010-08-31 H Lundbeck As Gaboksadol do leczenia depresji i innych zaburzeń afektywnych
TW200528098A (en) * 2003-12-18 2005-09-01 Lundbeck & Co As H Treatment of insomnia in human patients
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP2292222A1 (en) 2005-01-28 2011-03-09 H. Lundbeck A/S Polymorphic Forms of a GABAA Agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
JP5792061B2 (ja) * 2008-05-30 2015-10-07 サイコジェニックス・インコーポレーテッドＰｓｙｃｈｏｇｅｎｉｃｓ Ｉｎｃ． 神経及び精神障害の治療法
CA2732636A1 (en) * 2008-09-01 2009-05-07 H. Lundbeck A/S Pharmaceutical composition comprising gaboxadol and an inhibitor of pat1 or oat
WO2013090452A1 (en) 2011-12-12 2013-06-20 Orbis Biosciences, Inc. Sustained release particle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315934A (en) * 1979-09-24 1982-02-16 Sandoz Ltd. Organic compounds
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
CA2385749A1 (en) * 1999-09-28 2001-04-05 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same

Also Published As

Publication number Publication date
WO2002094225A1 (en) 2002-11-28
NZ547636A (en) 2008-03-28
AR033896A1 (es) 2004-01-07
EA200301282A1 (ru) 2004-04-29
IL158733A0 (en) 2004-05-12
CA2447603A1 (en) 2002-11-28
BG108441A (en) 2005-02-28
AU2002338855B2 (en) 2007-08-16
UA80092C2 (en) 2007-08-27
PL366541A1 (en) 2005-02-07
NO20035146L (no) 2003-11-19
SK15542003A3 (sk) 2004-05-04
HUP0400051A2 (hu) 2004-04-28
CZ20033269A3 (en) 2004-03-17
US20040157876A1 (en) 2004-08-12
KR20030097890A (ko) 2003-12-31
EA009731B1 (ru) 2008-02-28
JP2004530695A (ja) 2004-10-07
CN1511026A (zh) 2004-07-07
HRP20030950A2 (en) 2005-08-31
BR0209834A (pt) 2004-06-15
EP1389091A1 (en) 2004-02-18
EA200700703A1 (ru) 2007-08-31
MEP6308A (xx) 2010-02-10
IS7020A (is) 2003-11-10
MXPA03010596A (es) 2004-03-09
ZA200308594B (en) 2004-11-04
NO20035146D0 (no) 2003-11-19

Similar Documents

Publication Publication Date Title
HK1050526A1 (en) New a-amino acid compounds, a process for their preparation and pharmaceutical compositions containing them.
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
HUP0103987A3 (en) Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates
IL145430A0 (en) N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same
WO2004082615A3 (en) A process for preparing sustained release tablets
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
IL164857A (en) 1-thia-4,8,diaza-spiro[4.5]decan-3-one compounds, process for preparation thereof and pharmaceutical compositions comprising them
HUP0105437A3 (en) Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
AU7642001A (en) Novel $G(Y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
MXPA04003636A (es) Composiciones farmaceuticas que comprenden acido micofenolico o sal de micofenolato.
HU0102813D0 (en) New betha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
WO2003087050A3 (fr) Sel de perindopril et les compositions pharmaceutiques qui le contiennent
AU2001258677A1 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
PL365379A1 (en) Novel compounds having hypolipedemic, hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them
HK1054697A1 (en) Pharmaceutical preparations
BG108441A (en) Granular preparations of gaboxadol
AU2003202719A1 (en) Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them.
HUP0303813A3 (en) Arylsulfonamides as antiviral agents, process for preparation of the compounds and pharmaceutical compositions containing them
WO2001000617A3 (en) Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
AU2003231920A1 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
AU2002306687A1 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
HUP0201024A3 (en) Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them
UA81610C2 (ru) Изохинолиновые соединения, способ их получения и фармацевтическая композиция, которая их содержит